GB0203830A
GB0203830D0
(en)
|
2002-02-18 |
2002-02-18 |
Improving drug delivery to the respiratory tract
|
DK03739577.9T
DK1549337T3
(en)
|
2002-02-18 |
2003-02-14 |
COMBINATION OF DNASE I AND GLYCOSAMINOGLYCANES FOR USE IN EXTRACELLULAR DNA CLEARANCE
|
AU2003207317A
AU2003207317A1
(en)
|
2002-02-18 |
2003-02-14 |
Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
|
EP03704789.1A
EP1511466B2
(en)
|
2002-02-18 |
2003-02-14 |
Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
|
PT37395779T
PT1549337E
(en)
|
2002-02-18 |
2003-02-14 |
Combination of dnase i and glycosaminoglycans for use in extracellular dna clearance
|
AU2003245794A
AU2003245794A1
(en)
|
2002-02-18 |
2003-02-14 |
Glycosaminoglycan-dnase combination therapy
|
CA2516318A
CA2516318C
(en)
|
2002-02-18 |
2003-02-14 |
Use of glycosaminoglycans such as heparin for the treatment of respiratory disorders such as copd
|
PCT/GB2003/000663
WO2003068187A1
(en)
|
2002-02-18 |
2003-02-14 |
Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
|
ES03702776.0T
ES2565028T3
(en)
|
2002-02-18 |
2003-02-14 |
Combination therapy for respiratory disorders
|
AT03704789T
ATE410147T1
(en)
|
2002-02-18 |
2003-02-14 |
USE OF GLYCOSAMIN GLYCANS SUCH AS HEPARIN TO TREAT RESPIRATORY DISEASES SUCH AS COPD
|
PCT/GB2003/000703
WO2003068188A1
(en)
|
2002-02-18 |
2003-02-14 |
Combination therapy for respiratory disorders
|
DK03702776.0T
DK1513502T3
(en)
|
2002-02-18 |
2003-02-14 |
Combination therapy for airway disorders
|
EP03702776.0A
EP1513502B1
(en)
|
2002-02-18 |
2003-02-14 |
Combination therapy for respiratory disorders
|
CA2516331A
CA2516331C
(en)
|
2002-02-18 |
2003-02-14 |
Combination therapy using glycosaminoglycans and therapeutic agents for the treatment of respiratory disorders
|
ES03739577.9T
ES2527096T3
(en)
|
2002-02-18 |
2003-02-14 |
Combination of DNase I and glycosaminoglycans for use in cleaning extracellular DNA
|
DK03704789.1T
DK1511466T4
(en)
|
2002-02-18 |
2003-02-14 |
Use of glycosaminoglycans, such as, for example, heparin, for the treatment of respiratory disorders such as COPD
|
PCT/GB2003/000668
WO2003068254A1
(en)
|
2002-02-18 |
2003-02-14 |
Glycosaminoglycan-dnase combination therapy
|
PT03704789T
PT1511466E
(en)
|
2002-02-18 |
2003-02-14 |
Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
|
CA2516322A
CA2516322C
(en)
|
2002-02-18 |
2003-02-14 |
Glycosaminoglycan-dnase combination therapy
|
ES03704789.1T
ES2315479T5
(en)
|
2002-02-18 |
2003-02-14 |
Use of glycosaminoglycans such as eg Heparin for the treatment of respiratory disorders such as COPD
|
DE60323973T
DE60323973D1
(en)
|
2002-02-18 |
2003-02-14 |
USE OF GLYCOSAMINO LYCANES SUCH AS FOR EXAMPLE. HEPARIN FOR THE TREATMENT OF RESPIRATORY DISEASES SUCH AS COPD
|
EP03739577.9A
EP1549337B1
(en)
|
2002-02-18 |
2003-02-14 |
Combination of DNase I and glycosaminoglycans for use in extracellular DNA clearance
|
AU2003205898A
AU2003205898A1
(en)
|
2002-02-18 |
2003-02-14 |
Combination therapy for respiratory disorders
|
HK05107959.9A
HK1074582A1
(en)
|
2002-02-18 |
2005-09-09 |
Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
|